Last reviewed · How we verify
NCT07387679
Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity
NA trial testing Myo-inositol in Polycystic Ovarian Syndrome in 60 participants. Completed in 28 May 2025.
28 May 2025
Quick facts
| Lead sponsor | Muhammad Aamir Latif |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 29 November 2024 |
| Primary completion | 28 May 2025 |
| Estimated completion | 28 May 2025 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Myo-inositol — full drug profile →
- Metformin (metformin) — full drug profile →
Conditions studied
- Polycystic Ovarian Syndrome — all drugs for Polycystic Ovarian Syndrome →
Sponsor
Muhammad Aamir Latif — full company profile →
Who can join
Adults 18 to 45, female only, with Polycystic Ovarian Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There are considerable gaps in the comparative effectiveness and tolerability of myo-inositol and metformin for treating obesity in patients with polycystic ovarian syndrome (PCOS). The current study aimed to give insights comparing myo-inositol versus metformin for treating obesity in patients with PCOS.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07387679
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Myo-inositol
Trials testing the same drug.
- NCT06575868 — Myo-inositol During Pregnancy to Prevent Gestational Diabetes · NA · recruiting
- NCT05678114 — Inositol Treatment in Different Type of PCOS Phenotype · NA · completed
- NCT04892186 — Effects of Myo-inositol in Women With Polycystic Ovary Syndrome · NA · completed
- NCT04576546 — Inositols and FSH in IVF · NA · completed
- NCT04204044 — Comparison of Myoinositol and Metformin in PCO · EARLY_PHASE1 · unknown
Other recruiting trials for Polycystic Ovarian Syndrome
Currently open trials in the same condition.
- NCT06587698 — Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS · NA · recruiting
- NCT05858307 — Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements · recruiting
Other Muhammad Aamir Latif trials
Trials by the same sponsor.
- NCT07462182 — Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction · NA · not yet recruiting
- NCT07426744 — Antipyretic Therapy With and Without Cold Sponging · NA · not yet recruiting
- NCT07437391 — Effect of L-Carnitine Supplementation in Preterm Neonates · NA · recruiting
- NCT07313670 — Outcome of Using Hydrocortisone in Early Treatment of Pediatric Septic Shock · NA · not yet recruiting
- NCT07305935 — Comparison of Early Caffeine Administration Vs Supportive Therapy in Preventing Acute Kidney Injury · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07387679 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Muhammad Aamir Latif
- Last refreshed: 4 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07387679.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing